Alexion to Report First Quarter Results and Provide Update on COVID-19 on Wednesday, May 6th, 2020
April 09 2020 - 5:25PM
Business Wire
- Company Announces 2020 Annual Shareholder
Meeting To Be Held Virtually -
Alexion Pharmaceuticals, Inc.
(Nasdaq: ALXN) today announced that the Company will report its
financial results for the first quarter ended March 31, 2020 before
the US financial markets open on May 6, 2020. Following the release
of the financial results, Alexion management will conduct a
conference call and audio webcast at 8:00 a.m. Eastern Time
(ET).
The Company is actively evaluating the potential impact of
COVID-19 on the business and plans to provide an update on the
call. For additional information on Alexion’s ongoing efforts
related to COVID-19, please visit:
https://alexion.com/our-commitment/covid-19. Alexion intends to use
this website as a means of disclosing material non-public
information on COVID19 matters and for complying with its
disclosure obligations under SEC Regulation FD. Accordingly,
investors should monitor such portions of the Company’s website, in
addition to following the Company’s press releases, SEC filings and
public conference calls and webcasts.
To participate in this conference call, dial (866) 762-3111
(USA) or (210) 874-7712 (International), conference ID 1645087
shortly before 8:00 a.m. ET. The audio webcast can be accessed on
the Investor page of http://ir.alexion.com and an archived version
will be available for a limited time following the
presentation.
2020 Annual Shareholder Meeting
Alexion will host its 2020 annual meeting of shareholders
virtually due to the public health impact of the coronavirus
pandemic and to prioritize the health and well-being of meeting
participants.
The 2020 annual meeting of shareholders will be held in a
virtual format only at 5:30 p.m. (ET) on Wednesday, May 13, 2020.
Shareholders will not be able to attend the 2020 annual meeting in
person.
Shareholders at the close of business on the record date, March
16, 2020, are entitled to attend the 2020 annual meeting. To be
admitted to the meeting at
www.virtualshareholdermeeting.com/ALXN2020, shareholders must enter
the 16-digit voting control number found on their proxy card,
voting instruction form, notice of internet availability of proxy
materials or email previously received.
Please note that the proxy card and voting instruction form
included with previously distributed proxy materials will not be
updated to reflect the change from an in-person meeting to a
virtual-only meeting and may be used to vote shares in connection
with the annual meeting. Whether or not shareholders plan to attend
the virtual-only annual meeting, Alexion urges shareholders to vote
and submit their proxies in advance of the meeting by one of the
methods described in the proxy materials.
[ALXN-G]
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200409005833/en/
Investors Chris Stevo Head of Investor Relations (857)
338-9309
Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From Apr 2023 to Apr 2024